ArticleVirology journal2022

Interleukin-17A pretreatment attenuates the anti-hepatitis B virus efficacy of interferon-alpha by reducing activation of the interferon-stimulated gene factor 3 transcriptional complex in hepatitis B virus-expressing HepG2 cells.

Jiaxuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.